Epidemiology reports helps to understand the prevalence and incidence data of chosen indication by geography through methodical research using various sources. FirstView Insight’s epidemiology reports, by focusing on prevalence and incidence data helps to understand the severity of the disease, and its characterization in terms of age, sex and subtypes to report epidemiological information. This report helps in evaluating the size of the overall addressable market and how market dynamics may change according to disease epidemiology.
FirstView’s market review reports helps to estimate the market size, by evaluating both historical and forecasted data. The report majorly focusses on 7 major markets (7MM) including the US, EU5(France, Germany, Italy, Spain and UK) and ROW (Rest of World). The report provides comprehensive business study which helps the buyers to understand the market dynamics and future scope, upcoming players who might change the market scenario, also illustrating significant trends and recent developments in the therapeutic landscape. This helps the customers to secure collaborations and licensing deals by analyzing the top players in the market and understanding the global outlook from angles of players, regions, market types.
FirstView Insight offers pipeline drug profiles which paves the path to understand the future of medicine. We cover more than 800+ indications, 700+ mechanism of action. These reports provide detailed profile of all the clinical and non-clinical therapeutic molecules covering all R&D related activities along with commercial, designation, patent information. The promising candidates are highlighted—which can have potential commercial success and ultimately an impact on the wider healthcare. These reports help clients in identifying major competitive threat in their therapeutic space.
Healthcare industry has seen surge in new therapies, targets, technologies in the last decade, fundamentally because of exponential advances in innovation and expanded research in the field of bioscience. At FirstView Insight we have committed groups of investigators, concentrating on identifying new research capacities to guarantee that our customers consistently get the most updated information to take care of business. Our report store specifically focusses on new and emerging therapeutic options such CAR-T, Gene Therapy, Stem Cells Therapy, Immuno-Oncology, Orphan Drugs, Biosimilars and significantly more. The reports give boundless information including drug profile, clinical development, market size, benchmarking against contenders and much more.
FirstView’s Drug Review reports provides details of marketed drugs and emerging drugs including its mechanism of action, route of administration, clinical landscape, patent and market exclusivity data. The report also provides historical and forecasted sales data. These reports help clients in identifying major competitive threat in their therapeutic space
FirstView’s Launch Review reports helps to understand the launch timelines of competitors in that specific disease area. We provide wide coverage on start date, completion date and primary completion date to guide the client in planning the key milestones to stay ahead of competition and cognize of the upcoming product launches. We play a crucial role in helping you ascertain the correct details in shaping your launch strategy.